Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Asterias Biotherapeutics Inc ASTY

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:ASTY)

Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT

PR Newswire October 6, 2014

Asterias Biotherapeutics Announces Distribution Date of BioTime Warrants and Conversion Date of Series B Common Stock into Series A Common Stock

Business Wire September 29, 2014

BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology Partner for Clinical Trial of Immunotherapy Vaccine for Lung Cancer

Business Wire September 11, 2014

Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer

PR Newswire September 11, 2014

Asterias Biotherapeutics Announces Record Date for Distribution of BioTime Warrants to Holders of Asterias Series A Common Stock

PR Newswire September 4, 2014

BioTime Subsidiary Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients With Cervical Complete Spinal Cord Injury

Business Wire August 27, 2014

Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury

PR Newswire August 27, 2014

Asterias Biotherapeutics Announces Investor Briefing Conference Call and Webcast

PR Newswire August 25, 2014

Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution

PR Newswire August 21, 2014
View More News ››

Opinion & Analysis (GREY:ASTY)

Drug pricing, presidential politics, and three biotechs with promise

The Life Sciences Report April 13, 2016

How three companies have been resurrected from failed clinical trials:George Zavoico of JonesTrading

The Life Sciences Report April 6, 2016

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016
View More Opinion ››

Bullboard Posts (GREY:ASTY)

Be the first to post on this bullboard.

Western Exploration Inc

Western Exploration Inc

Western Exploration Inc. is focused on gold and silver discoveries in Northern Nevada. The Company is engaged in the business ...
View More »